Webinar: Pharmacy-led Implementation of Lipid Lowering Therapies in Primary Care.
This promotional webinar has been funded and developed by Novartis UK Ltd and is intended for UK healthcare professionals only.
Webinar Details
This promotional webinar has been funded and developed by Novartis UK Ltd and is intended for UK healthcare professionals only.
Pharmacy-led Implementation of Lipid Lowering Therapies in Primary Care
Wednesday 3rd December
1pm - 2pm
Three key takeaways
- Emphasise the urgency to lower LDL-C to target, defining the secondary prevention LDL-C targets and national guidelines.
- Real-world experiences of implementing lipid lowering therapies within general practice including practical tips for identifying and initiating patients eligible for escalated lipid lowering therapy.
- Share learnings and discuss importance of the role of pharmacy teams in implementing lipid lowering therapies in primary care.
Chair:
Nipa Patel, PCPA Regional Vice President - London and SE| Lead Pharmacist SASSE 2 & 3
Speakers:
Prof Raj Thakkar, PCCS President and CKD representative GP Partner
Sarah Trust, MPharm Clinical Pharmacist, Brighton & Sussex PCN
Speaker
Prof.Raj Thakkar
Raj's roles include GP partner, primary care cardiology lead for the Oxford Health Innovation Network and member of the national cardiac transformation programme (NHSE). He is also on the national EAGs for lipids, heart attack and heart failure. Raj is President of the Primary Care Cardiovascular Society, Honorary Visiting Professor at Cardiff University Medical School, Head of Medical External Engagement and Innovation for AstraZeneca, and UK medical director for Healthy.io. Previous roles have included Clinical Commissioning Director for Bucks CCG/BOB ICB in planned care and Cardiac Lead for the TVSCN.
Sarah Trust
Sarah Trust MPharm, Independent Prescriber is a clinical pharmacist specialising in lipid management and cardiovascular prevention. She established and runs dedicated lipid clinics within Brighton & Sussex PCNs, prescribing across the full range of lipid lowering therapies.
Her work has transformed treatment-to-target rates in both primary and secondary prevention, embedding structured pathways that reduce cardiovascular risk, improve patient outcomes and deliver sustainable, cost-effective care.
Job code: FA-11533242 | October 2025
